Table 1 Baseline patient characteristics of the enrolled patients

Age [years, median (IQR)]

57(32–83)

M:F radio

57:10

Cirrhosis/Non-Cirrhosis

18/49

Etiology (HBV/HCV/AH)

46/1/1

Clinical biochemical testing

 AFP (> 20 ng/ml)

33

 CEA (> 5U/ml)

21

 CA19-9 (> 37U/ml)

9

Patient status

 Staging

59

 Recurrence detection after treatment

8

Tumor number

 Solitary

32

 Multifocal

35

Macrovascular invasion (Yes/No)

18/49

Tumor staging (Initial evaluation)

 T1

16

 T2

13

 T3

14

 T4

16

Extrahepatic Lesions (N/total)

13/67

 Lymph node metastasis

7

 Distant metastasis

9